Effect of low-dose aspirin in a murine model of active tuberculosis

V. Kroesen (Bramsche, Germany)

Source: International Congress 2017 – Human susceptibility to tuberculosis
Session: Human susceptibility to tuberculosis
Session type: Poster Discussion
Number: 3042
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Kroesen (Bramsche, Germany). Effect of low-dose aspirin in a murine model of active tuberculosis. 3042

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of combined therapy using rosuvastatin and dihydroarteminin in a pulmonary malaria mouse model.
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

Effect of clarithromycin alone and clarithromycin containing regimen for mycobacteriun avium complex pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 558s
Year: 2006

Switch effects from daily to intermittent treatment with a daily regimen dosage for Mycobacterium avium complex pulmonary disease
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019


Comparative study of therapeutic effects of combination chemotherapy including various doses of clarithromycin for pulmonary Mycobacterium avium complex disease
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010


Effect of isoniazid prophylaxis for latent TB on interferon-gamma response
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


Effect of ICS/LABA combination in an ex vivo model of COPD exacerbation
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Comparison of efficacy and safety of fixed-dose combination regimen versus separate drugs for treatment of tuberculosis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019

Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients
Source: Eur Respir J 2014; 44: 1373-1375
Year: 2014


Effects of complex treatment with izofon of a pulmonary tuberculosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004

Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


Treatment of severe Mycobacterium avium complex pulmonary disease with a adjunctive amikacin and clofazimine versus standard regimen alone, a retrospective study
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019




Effect on treatment of giving information about tuberculosis to the tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 644s
Year: 2005

Efficacy and safety of levamisole as an immunomodulator in the treatment of drug resistant tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018




Effect of additional drug resistance of M tuberculosis in patients with Hr-TB on the efficacy of chemotherapy
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Treatment outcome of combination antibiotic therapy including clarithromycin for Mycobacterium avium complex pulmonary disease
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010

Effect of azithromycin treatment on inflammation in COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function
Source: Eur Respir J, 55 (3) 1901692; 10.1183/13993003.01692-2019
Year: 2020



Effect of genotype on hypersensitivity pneumonitis despite treatment.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



Long-term results of drug resistant tuberculosis treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 378s
Year: 2006